4D Pharma Plc

University College Cork

The Procter Gamble Company

Alimentary Health Limited

Agriculture and Food Development Authority (Teagasc)

Enterprise Ireland (Trading as Bioresearch Ireland)

Enterprise Ireland

Agriculture and Food Development Authority

Fergus Shanahan

Ian Jeffery

Paul O'Toole

Imke Elisabeth Mulder

Liam Diarmuid O'Mahony

John Kevin Collins

Helene Savignac

Alex Stevenson

Barry Kiely

Gerald Christopher O'Sullivan

Ker-Sang Chen

Fangyi Luo

Ross Peter Phillipson

Paul Ross

Catherine Stanton

Noel Caplice

Gerald F Fitzgerald

Katryna Cisek

Burkhardt Flemer

Paul O'toole

Gerald Christopher O'sullivan

Fangi Luo

Barry Pius Kiely

A method of determining colorectal cancer status in an individual, which comprises abundance profiling of the individual's microbiome.

Methods of determining colorectal cancer status in an individual

Provided are compositions comprising a bacterial strain of the genus, for use in a method of increasing the microbiota diversity and/or stability of the microbiota of a subject.

Compositions comprising bacterial strains

Provided are compositions comprising a bacterial strain of the genus, for use in a method of increasing the microbiota diversity and/or inducing stability of the microbiota of a subject.

An isolated(DPC6426) strain deposited with the National Collection of Industrial and Marine Bacteria Limited (NCIMB) on 27 Jul. 2012 under NCIMB Deposit Accession No. 42015.

Exopolysaccharide-producing bacteria, and uses thereof for protecting heart health

Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.

Methods of determining efficacy of treatments of diseases of the bowel

Methods of determining efficacy of treatments of inflammatory diseases of the bowel

Astrain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.

[object Object]

A strain ofisolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.

Bifidobacterium in the treatment of inflammatory disease

Growing community of inventors

Kinsale, Ireland

Fergus Shanahan